388 related articles for article (PubMed ID: 24252473)
1. Dendritic cells generated with Flt3L and exposed to apoptotic cells lack induction of T cell anergy and Foxp3⁺ regulatory T cell conversion in vitro.
Pletinckx K; Lutz MB
Immunobiology; 2014 Mar; 219(3):230-40. PubMed ID: 24252473
[TBL] [Abstract][Full Text] [Related]
2. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.
Gleisner MA; Rosemblatt M; Fierro JA; Bono MR
Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264
[TBL] [Abstract][Full Text] [Related]
3. Generation of dendritic cells with regulatory properties.
Ureta G; Osorio F; Morales J; Rosemblatt M; Bono MR; Fierro JA
Transplant Proc; 2007 Apr; 39(3):633-7. PubMed ID: 17445563
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
[TBL] [Abstract][Full Text] [Related]
6. Induction of tolerogenic vs immunogenic dendritic cells (DCs) in the presence of GM-CSF is regulated by the strength of signaling from monophosphoryl lipid A (MPLA) in association with glutathione and fetal hemoglobin gamma-chain.
Khatri I; Alexander C; Brandenburg K; Fournier K; Mach JP; Rietschel ET; Ulmer AJ; Terzioglu E; Waelli T; Gorczynski RM
Immunol Lett; 2009 May; 124(1):44-9. PubMed ID: 19379773
[TBL] [Abstract][Full Text] [Related]
7. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694
[TBL] [Abstract][Full Text] [Related]
9. Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3
Iwabuchi R; Ikeno S; Kobayashi-Ishihara M; Takeyama H; Ato M; Tsunetsugu-Yokota Y; Terahara K
Front Immunol; 2018; 9():1042. PubMed ID: 29892279
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells.
Zhan Y; Vega-Ramos J; Carrington EM; Villadangos JA; Lew AM; Xu Y
Eur J Immunol; 2012 Nov; 42(11):2889-900. PubMed ID: 22806691
[TBL] [Abstract][Full Text] [Related]
11. Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.
Schutt CR; Gendelman HE; Mosley RL
Mol Neurodegener; 2018 May; 13(1):26. PubMed ID: 29783988
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
13. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
Lim SN; Kuhn S; Hyde E; Ronchese F
J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
[TBL] [Abstract][Full Text] [Related]
14. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.
Curiel-Lewandrowski C; Mahnke K; Labeur M; Roters B; Schmidt W; Granstein RD; Luger TA; Schwarz T; Grabbe S
J Immunol; 1999 Jul; 163(1):174-83. PubMed ID: 10384114
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
16. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
[TBL] [Abstract][Full Text] [Related]
17. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.
Brasel K; De Smedt T; Smith JL; Maliszewski CR
Blood; 2000 Nov; 96(9):3029-39. PubMed ID: 11049981
[TBL] [Abstract][Full Text] [Related]
18. Differential role of NF-κB, ERK1/2 and AP-1 in modulating the immunoregulatory functions of bone marrow-derived dendritic cells from NOD mice.
Guindi C; Ménard M; Cloutier A; Gaudreau S; Besin G; Larivée P; McDonald PP; Dupuis G; Amrani A
Cell Immunol; 2012; 272(2):259-68. PubMed ID: 22070873
[TBL] [Abstract][Full Text] [Related]
19. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro.
Lutz MB; Kukutsch NA; Menges M; Rössner S; Schuler G
Eur J Immunol; 2000 Apr; 30(4):1048-52. PubMed ID: 10760792
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells.
Kubo T; Hatton RD; Oliver J; Liu X; Elson CO; Weaver CT
J Immunol; 2004 Dec; 173(12):7249-58. PubMed ID: 15585847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
